Clinical Trials Sponsored by Hospital Provincia Cordillera

Total 1871 results

Hunan Province Tumor Hospital

Completed

Tumor Relapsed Study of Serum Trxr Activity in Advanced Non-small Cell Lung Cancer

Progression | Advanced Non-small Cell Lung Cancer | First Line Treatment | Carcinoembryonic Antigen | Thioredoxin Reductase Activity

China
Hunan Province Tumor Hospital

Completed

Aprepitant for Chemotherapy Induced Nausea and Vomiting in Chinese Advanced Non-small Cell Lung Cancers

Carcinoma, Non-small Cell Lung

China
Hunan Province Tumor Hospital

Completed

Correlation Research of Thioredoxin Reductase in Lung Cancer (TRCRLC)

Non-small Cell Lung Cancer | Benign Neoplasm of Lung

China
Hunan Province Tumor Hospital

Unknown

Clinical Trial of Erlotinib and Pemetrexed for Maintenance Treatment in Lung Adenocarcinoma

Lung Adenocarcinoma
Hunan Province Tumor Hospital

Unknown

Endostar Continued Pumping Into Vein Combining With Gemcitabine-Carboplatin to Treat Non-Small Cell Lung Cancer (NSCLC)

Non-small Cell Lung Cancer

China
Hunan Province Tumor Hospital

Not yet recruiting

Sunvozertinib Plus Anlotinib as 1L Treatment in EGFR Mutant Advanced NSCLC-RW (WUKONG-32-RW)

Non-small Cell Lung Cancer

China
Hunan Province Tumor Hospital

Not yet recruiting

Sunvozertinib Plus Anlotinib as 1L Treatment in EGFR-Sensitive Mutations Combined With Co-Mutations Advanced NSCLC (WUKONG-32)

Non-Small Cell Lung Cancer

China
Shanxi Province Cancer Hospital

Not yet recruiting

A Single-arm, Single-center, Open-label Phase II Study of Zanubrutinib Combined With R-CHOP/R-DHAP in Newly Diagnosed Mantle CellLymphoma Patients (Z+RCHOP/RDHAP)

Mantle Cell Lymphoma

China
Hunan Province Tumor Hospital

Not yet recruiting

AK112 Plus Platinum-based Chemotherapy for EGFR/ALK/ROS1 Positve NSCLC (Apple)

Efficacy
Hunan Province Tumor Hospital

Recruiting

A Real-World Study of Treatment Patterns and Effectiveness in MET Mutation-Positive Advanced Lung Cancer

Advanced Lung Cancer

China
Hunan Province Tumor Hospital

Recruiting

A Real-World Study of Atezolizumab in Combination With Platinum-Based Doublet Chemotherapy as Neoadjuvant Therapy for Resectable Stage II-IIIB NSCLC

NSCLC

China
Hunan Province Tumor Hospital

Recruiting

Effect of Time-of-Day (ToD) for Immunochemotherapy on PFS in NSCLC (PACIFIC15)

Non-small Cell Lung Cancer

China
Hunan Province Tumor Hospital

Recruiting

High-dose Furmonertinib for First-line Treatment of EGFR Mutated NSCLC With Central Nervous System (CNS) Metastases

Non-Small Cell Lung Cancer

China
Hunan Province Tumor Hospital

Recruiting

Efficacy and Biomarker Explanation of IBI-323 + Bevacizumab Plus Platinum Based Chemotherapy on ALK-Rearranged NSCLC

Non Small Cell Lung Cancer

China
Hunan Province Tumor Hospital

Recruiting

Atezolizumab Combined With Platinum-based Chemotherapy as Neoadjuvant Therapy for Patients With Resectable Stage II-IIIB

Non Small Cell Lung Cancer

China
Hunan Province Tumor Hospital

Not yet recruiting

Pembrolizumab Plus Bevacizumab and Chemotherapy for ALK-rearranged NSCLC With Persistent 5'ALK

Lung Adenocarcinoma | ALK Gene Mutation | Immunotherapy

China
Hunan Province Tumor Hospital

Recruiting

JS-201 Combined With Lenvatinib in the Treatment of Small-cell Lung Cancer

Small-cell Lung Cancer

China
Hunan Province Tumor Hospital

Recruiting

The Efficacy and Safety of the Bispecific Anti-PD-1/PD-L1 Antibody IBI318 Combined With Lenvatinib in NSCLC.

Non-Small Cell Lung Cancer

China
Hunan Province Tumor Hospital

Recruiting

Survival Outcome of EGFR-TKI in Uncommon EGFR Mutant Advanced NSCLC

Non-small Cell Lung Cancer

China
Hunan Province Tumor Hospital

Recruiting

Chemotherapy or Chemotherapy Plus PD-1 Antibody in RET Fusion Positive Advanced NSCLC Patitnts: the POSEIDON Trial (POSEIDON)

Non-small Cell Lung Cancer

China
Hunan Province Tumor Hospital

Recruiting

Real World Study on Erlotinib/Gefitinib Combined With Bevacizumab in Advanced Non-aquamous Non-small Cell Lung Cancer

Non Small Cell Lung Cancer

China
Hunan Province Tumor Hospital

Completed

Association Between the Results of Specific Genetic Tests and the Efficacy of Targeted Therapies in Patients

Non-small Cell Lung Cancer

China
Hunan Province Tumor Hospital

Completed

Antitumor Activity and Safety of BEBT-109, a Novel EGFR Inhibitor, in Previously Treated NSCLC

NSCLC

China
Sichuan Province Orthopetic Hospital

Completed

Influence of Injury to the Kaplan Fibers in Adult and Pediatric Patients With ACL Injury

ACL-injury

China
Hunan Province Tumor Hospital

Completed

To Evaluate the Correlation Between the Results of Specific Gene Testing and the Efficacy of Targeted Therapy in Patients With NSCLC

Non Small Cell Lung Cancer

China
Hunan Province Tumor Hospital

Completed

The Prediction Biomarkers of Survival Outcome for Severe Immune-related Hepatitis

Lung Cancer

China
Hunan Province Tumor Hospital

Completed

Ethaselen for the Treatment of Thioredoxin Reductase High Expression Advanced Non-small Cell Lung Cancers

Carcinoma, Non-small Cell Lung

China
Hunan Province Tumor Hospital

Completed

Phase II Study on Sintilimab Combined With Docetaxel for Chemotherapy Failure Advanced NSCLC: the SUCCESS Study (SUCCESS)

Non-small Cell Lung Cancer

China
Hunan Province Tumor Hospital

Completed

Severe Adverse Events Biomarkers Investigation on Extensive Stage Small Cell Lung Cancer

Extensive Stage Small Cell Lung Cancer

China
Hunan Province Tumor Hospital

Completed

Efficacy and Safety of Immunotherapy in Non-small Cell Lung Cancer With Uncommon Histological Type (Esporta)

Uncommon Pathological Types of Lung Cancer

China
Shanxi Province Cancer Hospital

Unknown

Apatinib Plus Radiotherapy for Patients With Brain Metastases From Non-small-cell Lung Cancer

Brain Metastases
Hunan Province Tumor Hospital

Completed

Early Warning Study of Serum Thioredoixn Reductase Activity in Excised Non-small Cell Lung Cancers (EWSOTRILC)

Non-small Cell Lung Cancer Stage I | Non-small Cell Lung Cancer Stage IIIA | Non-small Cell Lung Cancer Stage II

China
Jie Zhong

Not yet recruiting

Intraoperative Application of Fluorescein Sodium Angiography in Vascular Retinopathy

Diabetic Retinopathy | Retinal Vein Occlusion | Vitreous Hemorrhage | Retinal Vasculitis | Vascular Retinopathy of Left Eye (Disorder) | Vascular Retinopathy of Right Eye (Disorder)
Westlake University
Zhejiang Provincial Tongde Hospital

Recruiting

TCM and Nutrition for Diabetes Care Cohort (TCM-Nut-DC)

Diabetes

China
Xuli Meng

Not yet recruiting

Nab-paclitaxel Compared With Docetaxel in the Neoadjuvant Chemotherapy Breast Cancer

Breast Cancer | Chemotherapy Effect
Lin Chen

Completed

Risk of Aspergillus Infection in Patients With Chronic Lung Disease

Fungal Infection Lungs

China
GuiBin Qiao

Active, not recruiting

Dynamic Evolution of Pulmonary Nodules and Influence Factors of Its Clinical Decision-making (DEPICT)

Pulmonary Nodule, Solitary | Pulmonary Nodule, Multiple

China
Jie Liu

Completed

The Etiology of New-onset Status Epilepticus

Status Epilepticus

China
Bai Jun

Unknown

Gefitinib Combined With Thalidomide to Treat NSCLC

NSCLC
Shanxi Provincial Maternity and Children's Hospital

Unknown

The Effect of Laser-assisted Zona Thinning on the Implantation Rate in the Women of Advanced Age

Female Urogenital Diseases

China
Shanxi Provincial Maternity and Children's Hospital

Unknown

The Effect of Low Oxygen Tension on the Early Development of Human Embryo in IVF/ICSI

Embryo Hypoxia

China
Changping Laboratory
Henan Provincial People's Hospital

Not yet recruiting

pBFS-guided Noninvasive Neuromodulation for Pre-school Children With ASD

Autism Spectrum Disorder
Fudan University
Zhejiang Provincial People's Hospital

Not yet recruiting

A Phase II Clinical Trial of Fruquintinib as Third Line Treatment in Advanced Pancreatic Cancer

Advanced Pancreatic Carcinoma

China
Fang Deng

Not yet recruiting

Efficacy and Safety of Broncho-Vaxom in the First Episode of Pediatric Idiopathic Nephrotic Syndrome

Nephrotic Syndrome in Children
Fundamenta Therapeutics, Ltd.
Anhui Provincial Hospital

Recruiting

Safety and Efficacy of ThisCART19 in Patients With Refractory or Relapsed B Cell Malignancies

B Cell Malignancy

China
Qinghua Xia,Prof

Not yet recruiting

A Study of Postoperative Adjuvant Chemotherapy for Upper Urinary Urothelial Carcinoma With Lymphovascular Invasion

Chemotherapy Effect

China
XueQing Yu

Recruiting

Intervention for High-normal Blood Pressure in Adults With Type 2 Diabetes (IPAD)

Diabetes Mellitus, Type 2 | Prehypertension | Blood Pressure | Cardiovascular Risk Factor | Adverse Event

China
XinLing Liang

Recruiting

China Collaborative Study on Epidemiology of Acute Kidney Injury

Acute Kidney Injury

China
Lin Chen

Completed

Esmolol in Sepsis Management:Evaluating Immunomodulatory Effects and Impact on Patient Outcomes

Sepsis | Cytokine Storm | Sympathetic Nervous System Diseases | Catecholamine; Overproduction | Immunologic Paralysis | Lymphocyte Disorder T | Beta-Blocker

China
Peng Liu

Completed

Improved Pain Management in Knee Osteoarthritis-related Surgeries

Knee Osteoarthritis | Pain Management | Total Knee Arthroplasty | Unicompartmental Knee Arthroplasty | High Tibial Osteotomy

China

3

Subscribe